For: | Gao Y, Zheng DY, Cui Z, Ma Y, Liu YZ, Zhang W. Predictive value of quantitative contrast-enhanced ultrasound in hepatocellular carcinoma recurrence after ablation. World J Gastroenterol 2015; 21(36): 10418-10426 [PMID: 26420968 DOI: 10.3748/wjg.v21.i36.10418] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i36/10418.htm |
Number | Citing Articles |
1 |
Zhen Liu, Xiaofei Wang, Lei Xing, Yan Pan, Shengchuan Huang. The Application Comparison of Contrast-Enhanced Ultrasound and Contrast-Enhanced Computed Tomography in Radiofrequency Ablation Treatment for Hepatocellular Carcinoma. Cancer Biotherapy and Radiopharmaceuticals 2019; 34(10): 621 doi: 10.1089/cbr.2019.2845
|
2 |
Peng-Hui Hu, Lan-Hong Pan, Patrick Ting-Yat Wong, Wen-Hui Chen, Yan-Qing Yang, Hong Wang, Jun-Jian Xiang, Meng Xu. <sup>125</sup>I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(21): 5033-5041 doi: 10.3748/wjg.v22.i21.5033
|
3 |
Jin-Yu Wu, Xiu-Mei Bai, Hong Wang, Qian Xu, Song Wang, Wei Wu, Kun Yan, Wei Yang. The Perfusion Features of Recurrent Hepatocellular Carcinoma After Radiofrequency Ablation Using Contrast-Enhanced Ultrasound and Pathological Stemness Evaluation: Compared to Initial Tumors. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01464
|
4 |
Weilu Chai, Liting Xie, Qiyu Zhao, Chao Cheng, Guo Tian, Tian'an Jiang, Pingping Wu. Ultrasound and Contrast-enhanced Ultrasound Findings after Percutaneous Irreversible Electroporation of Hepatic Malignant Tumors. Ultrasound in Medicine & Biology 2020; 46(3): 620 doi: 10.1016/j.ultrasmedbio.2019.12.012
|
5 |
Lu Zhang, Wei Zhou, WeiWei Zhan. Role of ultrasound in the assessment of percutaneous laser ablation of cervical metastatic lymph nodes from thyroid carcinoma. Acta Radiologica 2018; 59(4): 434 doi: 10.1177/0284185117721261
|
6 |
Miao Chen, Duo Wang, Yuan Zhao, Dan‑Mei Lu, Hong‑Xue Li, Jun‑Jie Liu, Hang Li. Preoperative color Doppler ultrasonography predicts early recurrence in AFP‑positive hepatocellular carcinoma. Oncology Letters 2019; doi: 10.3892/ol.2019.10825
|
7 |
Jieying Fu, Jia Tang, Huan Luo, Wencui Wu. The value of contrast-enhanced ultrasound in predicting postoperative recurrence of hepatocellular carcinoma. Medicine 2021; 100(22): e25984 doi: 10.1097/MD.0000000000025984
|
8 |
Yi Zhang, Ruiying Zheng, Ming Liu, Xiaoer Zhang, Yueting Sun, Hui Shen, Song Chen, Hongjie Cai, Wenbo Guo, Xiaoyan Xie, Baoxian Liu, Guangliang Huang. Quantitative Parameters of Contrast-Enhanced Ultrasound Predicting the Response to Combined Immune Checkpoint Inhibitor and Anti-angiogenesis Therapies for Unresectable Hepatocellular Carcinoma. Ultrasound in Medicine & Biology 2024; 50(3): 352 doi: 10.1016/j.ultrasmedbio.2023.11.005
|
9 |
Qi Zhang, Lili Wu, Daohui Yang, Yijie Qiu, Lingyun Yu, Yi Dong, Wen-Ping Wang. Clinical application of dynamic contrast enhanced ultrasound in monitoring the treatment response of chemoradiotherapy of pancreatic ductal adenocarcinoma. Clinical Hemorheology and Microcirculation 2020; 75(3): 325 doi: 10.3233/CH-190786
|
10 |
Xue Han, Jing Dong, Zhao Liu, Bolin Wu, Yuhang Tian, Haoyan Tan, Wen Cheng. Quantitative dynamic contrast-enhanced ultrasound to predict intrahepatic recurrence of hepatocellular carcinoma after radiofrequency ablation: a cohort study. International Journal of Hyperthermia 2020; 37(1): 1066 doi: 10.1080/02656736.2020.1817576
|
11 |
Qiu-Ping Ma, Xue-lei He, Kai Li, Jin-fen Wang, Qing-Jing Zeng, Er-Jiao Xu, Xu-qi He, Shuo-yang Li, Wang Kun, Rong-Qin Zheng, Jei Tian. Dynamic Contrast-Enhanced Ultrasound Radiomics for Hepatocellular Carcinoma Recurrence Prediction After Thermal Ablation. Molecular Imaging and Biology 2021; 23(4): 572 doi: 10.1007/s11307-021-01578-0
|
12 |
I. Wiesinger, L.P. Beyer, N. Zausig, N. Verloh, P. Wiggermann, C. Stroszczynski, E.M. Jung. Evaluation of integrated color-coded perfusion analysis for contrast-enhanced ultrasound (CEUS) after percutaneous interventions for malignant liver lesions: First results. Clinical Hemorheology and Microcirculation 2018; 69(1-2): 59 doi: 10.3233/CH-189131
|
13 |
Mariella Faccia, Matteo Garcovich, Maria Elena Ainora, Laura Riccardi, Maurizio Pompili, Antonio Gasbarrini, Maria Assunta Zocco. Contrast-Enhanced Ultrasound for Monitoring Treatment Response in Different Stages of Hepatocellular Carcinoma. Cancers 2022; 14(3): 481 doi: 10.3390/cancers14030481
|
14 |
Zhi-Dong Xuan, Li Zhou, Yu Wang, Xue Zheng. Prognostic value of the combination of serum levels of vascular endothelial growth factor, C-reactive protein and contrast-enhanced ultrasound in patients with primary liver cancer who underwent transcatheter arterial chemoembolization. Expert Review of Anticancer Therapy 2017; 17(12): 1169 doi: 10.1080/14737140.2017.1395284
|
15 |
E. Una Cidon, P. Alonso, B. Masters. Markers of Response to Antiangiogenic Therapies in Colorectal Cancer: Where are We Now and What should be Next?. Clinical Medicine Insights: Oncology 2016; doi: 10.4137/CMO.S34542
|
16 |
Yi-xin Hu, Cui-ju Yan, Miao Yun, Wei Zheng, Xue-bin Zou, Ya-fang Zhang, Ru-shuang Mao, Ling-ling Li, Jian-hua Zhou. Contrast-enhanced ultrasound liver imaging reporting and data system v2017: patient outcomes after treatment for early-stage hepatocellular carcinoma nodules with category 3-5 and category M. The British Journal of Radiology 2023; doi: 10.1259/bjr.20220492
|